Neuphoria Therapeutics Inc. (NEUP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 19.21M |
| Enterprise Value | -19.85B |
| P/E Ratio | -0.51 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 17.03 |
| Price/Book Ratio | 0.81 |
| Enterprise/Revenue | 0.14 |
| Enterprise/EBITDA | -0.01 |
| Fiscal Year | June 30, 2026 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -15.78 |
| Operating Margin | -11.88 |
| Return On Assets | -0.65 |
| Return On Equity | -0.77 |
| Revenue | 1.17M |
| Revenue/Share | 0.22 |
| Gross Profit | 511,210 |
| EBITDA | -16.45B |
| Net Income | -13.45B |
| Diluted EPS | -3.06 |
| Total Cash | 19.87M |
| Total Cash/Share | 3.67 |
| Total Debt | 34,345 |
| Total Debt/Equity | 0 |
| Current Ratio | 27.85 |
| Book Value Per Share | 4.55 |
| 52-Week Change | -62.47 |
| 52-Week High | 21.4 |
| 52-Week Low | 3.19 |
| Moving Average 50 Days | 3.76 |
| Moving Average 200 Days | 4.25 |
| Average Volume | 186,923 |
| Shares Outstanding | 5.4M |
| % Held by Institutions | 36.85 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | December 24, 2024 |